Home LiteratureArticle Details
PMID: 16609088 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine.

JAMA ·Vol. 295 ·No. 14 ·2006-04-12 ·Pages 1668-74

Poehling KA, Talbot TR, Griffin MR, Craig AS, Whitney CG, Zell E, Lexau CA, Thomas AR, Harrison LH, Reingold AL, Hadler JL, Farley MM, Anderson BJ, Schaffner W

Abstract

Streptococcus pneumoniae is a serious infection in young infants. A heptavalent pneumococcal conjugate vaccine (PCV7) was licensed in 2000 and recommended for all children aged 2 to 23 months. To determine the rates of invasive pneumococcal disease (IPD) in young infants before and after PCV7 was incorporated into the childhood immunization schedule in June 2000. A prospective, population-based study of infants aged 0 to 90 days who resided in areas in 8 US states with active laboratory surveillance for invasive S pneumoniae infections from July 1, 1997, to June 30, 2004. Rates of laboratory-confirmed IPD before (July 1, 1997-June 30, 2000) and after (July 1, 2001-June 30, 2004) PCV7 introduction, excluding a transition year (July 1, 2000-June 30, 2001). There were 146 cases of IPD, 89 before and 57 after PCV7 introduction. Isolated bacteremia occurred in 94 cases (64%), pneumonia in 27 (18%), meningitis in 22 (15%), and septic arthritis and/or osteomyelitis in 3 (2%). Mean rates of IPD for infants aged 0 to 90 days decreased 40% from 11.8 (95% confidence interval [CI], 9.6-14.5) to 7.2 (95% CI, 5.6-9.4; P = .004) per 100 000 live births following PCV7 introduction. Among black infants, mean rates of IPD decreased significantly from 17.1 (95% CI, 11.9-24.6) to 5.3 (95% CI, 2.8-10.1; P = .001) per 100,000 live births, with a nonsignificant decrease from 9.6 (95% CI, 7.3-12.7) to 6.8 (95% CI, 4.9-9.4) per 100,000 live births for white infants. Rates of PCV7-serotype isolates decreased significantly from 7.3 (95% CI, 5.3-10.1) to 2.4 (95% CI, 1.6-3.8; P<.001) per 100,000 live births, while rates of non-PCV7 serotypes remained stable (P = .55). Since PCV7 introduction, rates of IPD in young infants have decreased significantly, providing evidence that vaccinating children aged 2 to 23 months has led to changes in pneumococcal carriage in infants too young to receive PCV7. With a significant decrease in rates of IPD among black infants, the previous racial difference has been eliminated.

MeSH Terms
Drug Resistance, Bacterial Female Heptavalent Pneumococcal Conjugate Vaccine Humans Immunity, Herd Infant Infant, Newborn Male Meningococcal Vaccines Pneumococcal Infections/epidemiology,immunology,microbiology,prevention & control Pneumococcal Vaccines Population Surveillance Prospective Studies Serotyping Streptococcus pneumoniae/classification,drug effects United States/epidemiology Vaccines, Conjugate
Chemicals
Heptavalent Pneumococcal Conjugate Vaccine Meningococcal Vaccines Pneumococcal Vaccines Vaccines, Conjugate
Authors & Affiliations
14 authors, click to expand affiliations / ORCID
Poehling Katherine A
Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, TN 37232-2504, USA. [email protected]
Talbot Thomas R
Griffin Marie R
Craig Allen S
Whitney Cynthia G
Zell Elizabeth
Lexau Catherine A
Thomas Ann R
Harrison Lee H
Reingold Arthur L
Hadler James L
Farley Monica M
Anderson Bridget J
Schaffner William
Article Info
Journal
JAMA
Abbr.
JAMA
ISSN
1538-3598
Published
2006-04-12
Pages
1668-74
Language
English
Region
United States
NLM ID
7501160
Subset
IM
Grants
PHS HHS · U50/CCU416123 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]